4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-060939
Director acquired 3,086 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AZAB MOHAMMAD Director | 2022-12-12 | Option exercise | +3,086 | $2.68 | $8,270 | 69,905 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AZAB MOHAMMAD Director | 2022-12-12 | Option exercise · Stock Option (Right to Buy) | −3,086 | 0 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…